IL36A/IL1F6 Antikörper (AA 35-61)

Produktnummer ABIN2624092

Dieses Anti-IL36A/IL1F6-Antikörper ist ein Kaninchen Polyklonal-Antikörper zur Detektion von IL36A/IL1F6 in WB, ELISA, IHC und FACS. Geeignet für Human.

Kurzübersicht für IL36A/IL1F6 Antikörper (AA 35-61) (ABIN2624092)

Target: IL36A/IL1F6 (IL1F6) (Interleukin 1 Family, Member 6 (IL1F6))

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser IL36A/IL1F6 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), ELISA, Immunohistochemistry (IHC), Flow Cytometry (FACS)

Produktdetails anti-IL36A/IL1F6 Antikörper

Bindungsspezifität: AA 35-61

Spezifität: This IL1F6 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 35-61 amino acids from the Central region of human IL1F6.

Aufreinigung: Affinity purified

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: Approved: ELISA (1:1000), Flo (1:10 - 1:50), IHC (1:50 - 1:100), WB (1:100 - 1:500)

Kommentare:

Target Species of Antibody: Human

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: Lot specific

Buffer: PBS,  pH 7.2, 0.09 % sodium azide.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handhabung: Aliquot to avoid repeated freezing and thawing.

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: May be stored at 4°C for short-term only. Aliquot to avoid freeze-thaw cycles. Store at -20°C. Aliquots are stable for 1 year.

Details zu IL36A/IL1F6

Target: IL36A/IL1F6 (IL1F6) (Interleukin 1 Family, Member 6 (IL1F6))

Andere Bezeichnung: IL36A

Hintergrund: Name/Gene ID: IL36A
Family: IL-1

Synonyms: IL36A, FIL1, FIL1 epsilon, IL-1F6, IL1(EPSILON), IL1E, IL1F6, Interleukin 1, epsilon, Interleukin 36, alpha, Interleukin-1 epsilon, Interleukin-1 family member 6, FIL1(EPSILON), FIL1E, IL-1 epsilon, IL-1F6 (FIL-1-epsilon), Interleukin-36 alpha

Gen-ID: 27179

Pathways: Cancer Immune Checkpoints